Effects of antibiotics on biofilm and unattached cells of a clinical Staphylococcus aureus isolate from bone and joint infection

Journal of Medical Microbiology

Volumn 64, Issue 9, 2015, Pages 1021-1026

  Marquès, Claire ^a,b   Tasse, Jason ^c,d   Pracros, Anne ^b   Collin, Valérie ^a   Franceschi, Christine ^a   Laurent, Frédéric ^c,d   Chatellier, Sonia ^a   Forestier, Christiane ^b  

^a BIOMÉRIEUX   (France)

^b UNIVERSITÉ BLAISE PASCAL   (France)

^c HOSPICES CIVILS DE LYON   (France)

^d UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFTAROLINE; DAPTOMYCIN; ERYTHROMYCIN; FOSFOMYCIN; FUSIDIC ACID; GENTAMICIN; LINEZOLID; OFLOXACIN; OXACILLIN; PRISTINAMYCIN; RIFAMPICIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

ARTICLE; BACTERIAL CELL; BACTERIAL CLEARANCE; BACTERIAL VIABILITY; BACTERIOLYSIS; BACTERIUM ISOLATE; BIOFILM; BONE INFECTION; CELL VIABILITY; CONFOCAL MICROSCOPY; DRUG EFFECT; DRUG EFFICACY; IN VITRO STUDY; INFECTION RISK; INFECTIOUS ARTHRITIS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MICROBIAL BIOMASS; MINIMUM BACTERICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; DRUG EFFECTS; HUMAN; JOINT DISEASES; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; OSTEOMYELITIS; PHYSIOLOGY; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; BIOFILMS; HUMANS; JOINT DISEASES; MICROBIAL SENSITIVITY TESTS; OSTEOMYELITIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84941552132     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.000125     Document Type: Article

References (22)

1. Aggarwal, V. K., Bakhshi, H., Ecker, N. U., Parvizi, J., Gehrke, T. & Kendoff, D. (2014). Organism profile in periprosthetic joint infection: pathogens differ at two arthroplasty infection referral centers in Europe and in the United States. J Knee Surg 27, 399–406.
2. Bui, L. M. G., Hoffmann, P., Turnidge, J. D., Zilm, P. S. & Kidd, S. P. (2015). Prolonged growth of a clinical Staphylococcus aureus strain selects for a stable small-colony-variant cell type. Infect Immun 83, 470–481.
3. Cha, J. O., Park, Y. K., Lee, Y. S. & Chung, G. T. (2011). In vitro biofilm formation and bactericidal activities of methicillin-resistant Staphylococcus aureus clones prevalent in Korea. Diagn Microbiol Infect Dis 70, 112–118.
4. CLSI (2013). Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Third Informational Supplement M100-S23. Wayne, PA: Clinical and Laboratory Standards Institute.
5. Darouiche, R. O. (2004). Treatment of infections associated with surgical implants. N Engl J Med 350, 1422–1429.
6. Del Pozo, J. L. & Patel, R. (2009). Clinical practice. Infection associated with prosthetic joints. N Engl J Med 361, 787–794.
7. Donlan, R. M. & Costerton, J. W. (2002). Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15, 167–193.
8. Edwards, A. M. (2012). Phenotype switching is a natural consequence of Staphylococcus aureus replication. J Bacteriol 194, 5404–5412.
9. Evans, D. J., Brown, M. R., Allison, D. G. & Gilbert, P. (1990). Susceptibility of bacterial biofilms to tobramycin: role of specific growth rate and phase in the division cycle. J Antimicrob Chemother 25, 585–591.
10. Kaplan, J. B., Izano, E. A., Gopal, P., Karwacki, M. T., Kim, S., Bose, J. L., Bayles, K. W. & Horswill, A. R. (2012). Low levels of b-lactam antibiotics induce extracellular DNA release and biofilm formation in Staphylococcus aureus. MBiol 3, e00198-0012.
11. Mah, T. F., Pitts, B., Pellock, B., Walker, G. C., Stewart, P. S. & O’Toole, G. A. (2003). A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance. Nature 426, 306–310.
12. Meije, Y., Almirante, B., Del Pozo, J. L., Martín, M. T., Fernández- Hidalgo, N., Shan, A., Basas, J., Pahissa, A. & Gavaldà, J. (2014). Daptomycin is effective as antibiotic-lock therapy in a model of Staphylococcus aureus catheter-related infection. J Infect 68, 548–552.
13. Miró, J. M., Entenza, J. M., Del Río, A., Velasco, M., Castañeda, X., Garcia de la Mària, C., Giddey, M., Armero, Y., Pericàs, J. M. & other authors (2012). High-dose daptomycin plus fosfomycin is safe and effective in treating methicillin-susceptible and methicillinresistant Staphylococcus aureus endocarditis. Antimicrob Agents Chemother 56, 4511–4515.
14. Ng, M., Epstein, S. B., Callahan, M. T., Piotrowski, B. O., Simon, G. L., Roberts, A. D., Keiser, J. F. & Kaplan, J. B. (2014). Induction of MRSA biofilm by low-dose b-lactam antibiotics: specificity, prevalence and dose-response effects. Dose Response 12, 152–161.
15. Nguyen, D., Joshi-Datar, A., Lepine, F., Bauerle, E., Olakanmi, O., Beer, K., McKay, G., Siehnel, R., Schafhauser, J. & other authors (2011). Active starvation responses mediate antibiotic tolerance in biofilms and nutrient-limited bacteria. Science 334, 982–986.
16. Odenholt, I. (2001). Pharmacodynamic effects of subinhibitory antibiotic concentrations. Int J Antimicrob Agents 17, 1–8.
17. Siala, W., Mingeot-Leclercq, M. P., Tulkens, P. M., Hallin, M., Denis, O. & Van Bambeke, F. (2014). Comparison of the antibiotic activities of daptomycin, vancomycin, and the investigational fluoroquinolone delafloxacin against biofilms from Staphylococcus aureus clinical isolates. Antimicrob Agents Chemother 58, 6385–6397.
18. Singh, R., Ray, P., Das, A. & Sharma, M. (2010). Penetration of antibiotics through Staphylococcus aureus and Staphylococcus epidermidis biofilms. J Antimicrob Chemother 65, 1955–1958.
19. Stewart, P. S. & Costerton, J. W. (2001). Antibiotic resistance of bacteria in biofilms. Lancet 358, 135–138.
20. Suci, P. A., Mittelman, M. W., Yu, F. P. & Geesey, G. G. (1994). Investigation of ciprofloxacin penetration into Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother 38, 2125–2133.
21. Titécat, M., Senneville, E., Wallet, F., Dezèque, H., Migaud, H., Courcol, R. J. & Loïez, C. (2013). Bacterial epidemiology of osteoarticular infections in a referent center: 10-year study. Orthopaedics Traumatol Surg Res 99, 653–658.
22. Zhang, L. & Mah, T. F. (2008). Involvement of a novel efflux system in biofilm-specific resistance to antibiotics. J Bacteriol 190, 4447–4452.